Health
CSOFT’s health blog aims to provide insight into complex diseases, treatment options and regulatory developments, and other prevalent health issues people face today.
CSOFT Health Sciences Heads to DIA 2023, Illuminating Opportunities to Drive Diversity in Clinical Trials
As summer arrives in New England, we are excited to announce CSOFT Health Sciences will be returning as exhibitors to the DIA 2023 Global Annual Meeting in our home city of Boston, Massachusetts this June 25th-29th! With our extended team in town for the occasion and...
Multilingual Patient Communications: Parting Lessons of the Pandemic
As the World Health Organization joins the United States in calling an end to the pandemic, few want more than to move on from a time of unrelenting challenges, but that timing may not be so fortuitous when it comes to capturing its most important lessons for...
MedTech and Medical Device Localization: Leveraging ISO 13485 for Multilingual Quality Management
With so much of MedTech resembling a medical device, and with more medical devices incorporating software and other digital components, it is ever harder to define what is a MedTech and what is a medical device localization project. With the possibility some projects...
Linguistic Validation for eClinical Patient Questionnaires: Driving Patient Centricity Through eCOA Translations
When it comes to setting up a foundation for diverse, patient-centric clinical trials, linguistic validation is an essential localization practice that can help prepare patient questionnaires for participants in diverse global regions, an essential to succeeding in...
Reducing Clinical Trial Delays with IVD Translations
When conducting clinical trials in Europe and around the world, accurate and effective IVD translations help mitigate clinical trial delays that stand in the way of device approval. In vitro diagnostic medical devices (IVDs), also called in vitro diagnostic products,...
Can Clinical Trial Translations Improve Sponsor Diversity Index?
Following the premiere of Bioethics International’s new diversity index in 2023, how can clinical trial translations improve a company’s future rating? Diversity in clinical trials has been a hot topic in recent years, even prompting the U.S. Food and Drug...
Personalization and Patient-Centricity in Pharmaceutical Labeling Translations
Among the many steps it takes to bring a drug to market, pharmaceutical labeling translations may seem like one small hurdle to overcome on the way to approval. Medical translation of pharmaceutical labels, which can include labels on the carton or package and a host...
ChatGPT in Healthcare: A Tool to Improve Patient Communication and Medical Translations?
Since OpenAI publicly released ChatGPT, a generative artificial intelligence (AI) that uses a large language model to produce human-like text, the possibilities for ChatGPT have taken just about every communication and translation-heavy industry by storm. But in the...
ePRO Translations: Cultural Adaptation for the Decentralized Clinical Trial
Patient-reported outcome (PRO) translations have long required linguistic validation before use in clinical trials, so with the rise of digital instruments in decentralized clinical trials, what additional considerations are there for electronic PRO (ePRO)...
eLearning Translations: Improving Medical Device Use Around the Globe
How can medical device companies leverage eLearning translations to improve the use of medical devices around the world? While patients are the end user for many medical devices, healthcare professionals are responsible for guiding patients in correct use, as well as...
Categories
ABOUT US
CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com